Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community

Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company’s One Lambda brand representing leading in vitro diagnostic products for the transplant community.

Please to read the entire article.